Federal Register #0915-0345

HRSA Extends AIDS Drug Assistance Program Data Collection and Pediatric EMS Data Center Award

This notice from the Department of Health and Human Services (HHS), specifically the Health Resources and Services Administration (HRSA), concerns the extension of information collection for the AIDS Drug Assistance Program (ADAP) Data Report and an award extension for pediatric emergency medical data collection. - Government Buyer: - Department of Health and Human Services (HHS) - Sub-agencies: Health Resources and Services Administration (HRSA), Food and Drug Administration (FDA) - Products/Services Requested: - Annual collection of data from state and territory AIDS Drug Assistance Programs (ADAPs) under the Ryan White HIV/AIDS Program - Data includes recipient and de-identified client-level information on demographics, medication assistance, and health outcomes for low-income individuals with HIV - Extension of the Emergency Medical Services for Children Data Center award to the University of Utah - Supports national data collection on pediatric readiness in hospital emergency departments and prehospital EMS agencies - Unique or Notable Requirements: - No procurement of goods or commercial products; this is an information collection and program data reporting requirement - Data collection is used to evaluate program impact, monitor funding, and assess health outcomes - The FDA clarified that BILTRICIDE (praziquantel) 600 mg tablets remain approved for generic competition - No OEMs or commercial vendors are involved, as this is not a procurement action

Description

The Health Resources and Services Administration (HRSA) has submitted an Information Collection Request (ICR) to the Office of Management and Budget (OMB) for review and approval regarding the AIDS Drug Assistance Program Data Report. This program provides FDA-approved medications to low-income people with HIV through state and territory-administered grants. The data report includes recipient and client-level information to evaluate program impact and monitor funding use. Public comments are invited until May 13, 2026, to inform OMB's review.

View original listing